In contrast, Wang et al. did not observe any statistically significant differences in the concentration of IL-17 in the plasma of ovarian cancer patients, compared to the group with benign ovarian tumors and the group of healthy women [51]. This evidence concerns the gene IL17A and ovarian benign neoplasm.